United States · FDA National Drug Code directory
Ibandronate Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-6097_63d90e35-b379-2511-e5fd-b75c1d1d5dde
- Product NDC
- 60505-6097
- Form
- INJECTION
- Composition / generic term
- ibandronate sodium
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160113
- Source listing expiry
- 20271231
Source-listed ingredients
- IBANDRONATE SODIUM — 3 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (60505-6097-0) / 3 mL in 1 SYRINGE, GLASS · 60505-6097-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →